MRes Research Projects for Cancer Technology

Applications for October 2022 are now closed.

Applications for those wishing to start in October 2023 will open in October 2022.  See the guidelines below for the project selection process and example projects, though note that these instructions, deadlines, and projects will be updated later in the year to reflect the new admissions cycle information. 

MRes Cancer Technology students select their projects in October-November each year following opportunities to meet & discuss projects with supervisors. Projects draw from the diversity of research at Imperial and the Institute of Cancer Research and often include but are not limited to artificial intelligence, organ-on-chips, advanced imaging, nanotechnology, drug development and surgical technologies. There are typically 4-fold more projects than students, and all students have so far been allocated their first choice.  A sample of research projects that may be available for selection in the coming year as listed below. Because cancer research such is a rapidly changing field, project objectives often change to keep up.

Please visit our How do I apply? page for full details of the application process and deadlines.

List of Projects

SupervisorsProject Title
Amanda Foust & Chris Bakal A microscope that sees electricity: development of an optical imaging pipeline to evaluate cancer cell aggressiveness through electrical and morphological dynamics
Rylie Green & Amin Hajitou Implanted device development for targeted in-tumour delivery of chemotherapeutic
Sam Au & Jun Ishihara Investigating tumour-immune cell interactions for cancer immunotherapy using capillary-on-chip models
Sylvain Ladame & Jessica Strid Hydrogel-coated microneedle patches for diagnosis of skin cancers, at the point-of-care via detection of cancer-specific miRNA biomakers from skin interstitial fluid
Ruth McLauchlan & Josh Mason  Development of adaptive treatment techniques in head and neck radiotherapy
Nuria Oliva-Jorge & Iain McNeish  Selective and synergistic treatment of advanced ovarian cancer using DNA nanotechnology
Ali Yetisen & Louis Chesler  Lateral-Flow Assay Based Catecholamine Metabolite Detection in Neuroblastoma
Sam Au & Nicola Valeri  Self-assembled vascularised organoid-on-chip models to study the shedding of tumour DNA into circulation
Darryl Overby & Paul Huang  A Novel Organ-in-Chip Platform for Gynaecological Sarcomas
Darryl Overby & Emma Harris  An Organ-in-Chip Platform for Targeted Intra-Tumour Drug Delivery using Acoustic
Summary of the table's contents